CureMetrix is a startup based in the United States.
CureMetrix develops FDA-cleared AI-powered software that detects and localizes breast arterial calcifications on mammograms, enabling additional cardiovascular risk screening during routine breast cancer screening.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.